Luodan Yu

8.6k total citations · 5 hit papers
81 papers, 6.5k citations indexed

About

Luodan Yu is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Luodan Yu has authored 81 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Biomedical Engineering, 34 papers in Molecular Biology and 33 papers in Materials Chemistry. Recurrent topics in Luodan Yu's work include Nanoplatforms for cancer theranostics (62 papers), Nanoparticle-Based Drug Delivery (24 papers) and Extracellular vesicles in disease (24 papers). Luodan Yu is often cited by papers focused on Nanoplatforms for cancer theranostics (62 papers), Nanoparticle-Based Drug Delivery (24 papers) and Extracellular vesicles in disease (24 papers). Luodan Yu collaborates with scholars based in China and Singapore. Luodan Yu's co-authors include Yu Chen, Han Lin, Jianlin Shi, Xiaoqin Qian, Heliang Yao, Liying Wang, Yufang Zhu, Ping Hu, Caihong Dong and Wei Feng and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

In The Last Decade

Luodan Yu

78 papers receiving 6.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer Therapy

2016 602 citations Ping Huang, Xiaoqin Qian et al. Journal of the American Chemical Society profile →
Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice

2019 518 citations Wenwen Yue, Liang Chen et al. Nature Communications profile →
Bioinspired Copper Single‐Atom Catalysts for Tumor Parallel Catalytic Therapy

2020 327 citations Xiangyu Lu, Shanshan Gao et al. Advanced Materials profile →
Gas‐Generating Nanoplatforms: Material Chemistry, Multifunctionality, and Gas Therapy

2018 311 citations Luodan Yu, Yu Chen et al. Advanced Materials profile →
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu²⁺ Chelation-Initiated Nontoxicity-to-Toxicity Transition

2019 310 citations Wencheng Wu, Luodan Yu et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by Luodan Yu

Since Specialization

Citations

This map shows the geographic impact of Luodan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luodan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luodan Yu more than expected).

Fields of papers citing papers by Luodan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luodan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luodan Yu. The network helps show where Luodan Yu may publish in the future.

Co-authorship network of co-authors of Luodan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Luodan Yu. A scholar is included among the top collaborators of Luodan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luodan Yu. Luodan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug Delivery Systems for Enhancing Cancer Chemotherapy 2025 ·(unknown), Xueli Ren, Jie Liu, Luodan Yu	0
2	Alternating Interlayered Piezoelectric Self‐Heterojunction Boosts Sono‐Piezocatalytic Pyroptosis Oncotherapy 2025 ·Advanced Materials ·Guangru Li, Xinyue Dai, Yuling Liu, Jinli Chen, (unknown), Ping Li, Luodan Yu, Yu Chen	0
3	Dynamic DNA assembly-assisted CRISPR/Cas12a system for lung cancer-associated miRNA analysis 2025 ·Materials Today Bio ·Anzhi Sheng, Bingjie Zeng, Haizhen Jin, Kai Wang, (unknown), Lifang Ma, Luodan Yu, Ling Tian	2
4	Cell‐Membrane‐Camouflaged Biomimetic Nanomedicines for Cerebral Ischemia‐Reperfusion Injury Treatment 2025 ·Advanced Healthcare Materials ·Yihong Su, (unknown), Dingsheng Liu, Luodan Yu, Yu Chen	0
5	An “Outer Piezoelectric and Inner Epigenetic” Logic‐Gated PANoptosis for Osteosarcoma Sono‐Immunotherapy and Bone Regeneration 2024 ·Advanced Materials ·Xiaoting Wang, Xun Guo, (unknown), Xinran Song, Liang Chen, Luodan Yu, Jianli Ren, Yu Chen	20
6	Engineering versatile nano-bacteria hybrids for efficient tumor therapy 2023 ·Coordination Chemistry Reviews ·(unknown), (unknown), Guangru Li, Hui Huang, Xinran Song, Luodan Yu, Yu Chen	24
7	Multifunctional chemoreactive nanosonosensitizers exert antitumoral, antibacterial and wound healing effects on malignant peripheral nerve sheath tumors 2023 ·Chemical Engineering Journal ·(unknown), (unknown), Haibo Li, Chengjiang Wei, Luodan Yu, Yihui Gu, Qingfeng Li, Yu Chen, Zhichao Wang	4
8	Engineering nanoprobes for magnetic resonance imaging of brain diseases 2023 ·Chemical Engineering Journal ·Jingyi Zhang, Luodan Yu, Meihua Yu, Dehong Yu, Yu Chen, Jun Zhang	7
9	Engineering Self-Assembled Nanomedicines Composed of Clinically Approved Medicines for Enhanced Tumor Nanotherapy 2023 ·Nanomaterials ·(unknown), Luodan Yu, Yu Chen	6
10	Oxygen-evolving photosynthetic cyanobacteria for 2D bismuthene radiosensitizer-enhanced cancer radiotherapy 2022 ·Bioactive Materials ·(unknown), Luodan Yu, Caihong Dong, (unknown), Sheng Wang, Yu Chen, Qin Zhang	36
11	Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics 2021 ·Journal of Nanobiotechnology ·Liqiang Zhou, Minfeng Huo, Xiaoqin Qian, Li Ding, Luodan Yu, Wei Feng, Xin‐Wu Cui, Yu Chen	46
12	Bioinspired Copper Single‐Atom Catalysts for Tumor Parallel Catalytic Therapy breakdown → 2020 ·Advanced Materials ·Xiangyu Lu, Shanshan Gao, Han Lin, Luodan Yu, Yunhu Han, Piao Zhu, Weichao Bao, Heliang Yao, Yu Chen, Jianlin Shi	327
13	Ultrasmall Ag₂Te Quantum Dots with Rapid Clearance for Amplified Computed Tomography Imaging and Augmented Photonic Tumor Hyperthermia 2020 ·ACS Applied Materials & Interfaces ·Lile Dong, Wenjuan Li, Luodan Yu, Lining Sun, Yu Chen, Guobin Hong	39
14	Copper‐Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification 2020 ·Advanced Materials ·Wencheng Wu, Luodan Yu, Yinying Pu, Heliang Yao, Yu Chen, Jianlin Shi	182
15	Silicene: Wet‐Chemical Exfoliation Synthesis and Biodegradable Tumor Nanomedicine 2019 ·Advanced Materials ·Han Lin, Wujie Qiu, Jianjun Liu, Luodan Yu, Shanshan Gao, Heliang Yao, Yu Chen, Jianlin Shi	136
16	Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu²⁺ Chelation-Initiated Nontoxicity-to-Toxicity Transition breakdown → 2019 ·Journal of the American Chemical Society ·Wencheng Wu, Luodan Yu, (unknown), Minfeng Huo, Han Lin, Liying Wang, Yu Chen, Jianlin Shi	310
17	Self-evolved hydrogen peroxide boosts photothermal-promoted tumor-specific nanocatalytic therapy 2019 ·Journal of Materials Chemistry B ·Shanshan Gao, Xiangyu Lu, Piao Zhu, Han Lin, Luodan Yu, Heliang Yao, Chenyang Wei, Yu Chen, Jianlin Shi	66
18	Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice breakdown → 2019 ·Nature Communications ·Wenwen Yue, Liang Chen, Luodan Yu, Bangguo Zhou, Haohao Yin, Weiwei Ren, Chang Liu, Le‐Hang Guo, Yifeng Zhang, Liping Sun, Kun Zhang, Hui‐Xiong Xu, Yu Chen	518
19	Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery 2018 ·Biomaterials ·Luodan Yu, Yu Chen, Han Lin, Wenxian Du, Hangrong Chen, Jianlin Shi	141
20	Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer Therapy breakdown → 2016 ·Journal of the American Chemical Society ·Ping Huang, Xiaoqin Qian, Yu Chen, Luodan Yu, Han Lin, Liying Wang, Yufang Zhu, Jianlin Shi	602

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact